ingest
cdrApp
2018-03-15T14:52:04.811Z
d591f2cd-3da7-4b31-9dd8-ee27dcb6a3ee
modifyDatastreamByValue
RELS-EXT
fedoraAdmin
2018-03-15T14:52:55.370Z
Setting exclusive relation
addDatastream
MD_TECHNICAL
fedoraAdmin
2018-03-15T14:53:06.491Z
Adding technical metadata derived by FITS
addDatastream
MD_FULL_TEXT
fedoraAdmin
2018-03-15T14:53:29.343Z
Adding full text metadata extracted by Apache Tika
modifyDatastreamByValue
RELS-EXT
fedoraAdmin
2018-03-15T14:53:51.391Z
Setting exclusive relation
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-05-18T15:25:02.303Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-07-11T11:23:21.652Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-07-18T07:19:42.847Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-08-17T13:15:30.246Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-08-21T16:09:17.082Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-09-27T16:19:12.844Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-10-12T07:25:44.779Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-10-17T12:42:10.767Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2019-03-21T17:21:43.464Z
Brooke
Matson
Author
Department of Cell Biology and Physiology
School of Medicine
Molecular Regulators of Embryo Implantation and Pregnancy
Embryo implantation is one of the first steps in the establishment of pregnancy and sets the stage for proper embryonic and placental development. We are beginning to appreciate the complexity of implantation and its demand for synchrony between embryo and endometrium. Over the years, many groups have identified and studied both embryonic and endometrial factors affecting implantation, but there is still much to learn. Here, we focus on the endocrine peptide adrenomedullin (Adm, AM) and its association with female reproductive physiology and disease in both mice and humans.
In Part I, we elaborate on the subfertility phenotype of Adm heterozygous female mice by testing whether AM supplementation before implantation can improve fertility and pregnancy outcomes. We find that administration of AM directly to the mouse uterus before blastocyst transfer enhances implantation success and inter-embryonic spacing. Intra-uterine delivery of AM also confers morphological and cellular changes to the uterine epithelium and stroma that are associated with endometrial receptivity and believed to be beneficial for implantation. We also test mid-regional pro-adrenomedullin (MR-proADM), a stable surrogate for AM peptide, as a biomarker for endometriosis, which is comorbid with infertility. Our studies identify novel mechanisms of action of AM in the endometrium in support of implantation and the establishment of pregnancy, providing a foundational basis for the use of AM as a clinical therapeutic for infertility.
In Part II, we address the role of AM in the maintenance of a healthy pregnancy by expanding upon previous studies in mouse models with clinical samples from women with severe preeclampsia, a placental vascular disorder characterized by hypertension and proteinuria. Because Adm-/- placentas exhibit a preeclampsia-like phenotype, we test the hypothesis that MR-proADM concentrations are decreased in plasma from women with severe preeclampsia. Indeed, we find that MR-proADM levels are blunted in women with severe preeclampsia and that MR-proADM is similarly effective as other established biomarkers of preeclampsia at distinguishing between cases and controls. Altogether, our studies in both mice and humans point to diagnostic and therapeutic applications for AM in the context of female reproductive disease.
Winter 2017
2017
Physiology
Cellular biology
Endocrinology
adrenomedullin, endometriosis, implantation, in vitro fertilization, preeclampsia, pregnancy
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Cell Biology and Physiology
Kathleen
Caron
Thesis advisor
Keith
Burridge
Thesis advisor
Richard
Cheney
Thesis advisor
Robert
Tarran
Thesis advisor
Steven
Young
Thesis advisor
text
Brooke
Matson
Creator
Department of Cell Biology and Physiology
School of Medicine
Molecular Regulators of Embryo Implantation and Pregnancy
Embryo implantation is one of the first steps in the establishment of pregnancy and sets the stage for proper embryonic and placental development. We are beginning to appreciate the complexity of implantation and its demand for synchrony between embryo and endometrium. Over the years, many groups have identified and studied both embryonic and endometrial factors affecting implantation, but there is still much to learn. Here, we focus on the endocrine peptide adrenomedullin (Adm, AM) and its association with female reproductive physiology and disease in both mice and humans.
In Part I, we elaborate on the subfertility phenotype of Adm heterozygous female mice by testing whether AM supplementation before implantation can improve fertility and pregnancy outcomes. We find that administration of AM directly to the mouse uterus before blastocyst transfer enhances implantation success and inter-embryonic spacing. Intra-uterine delivery of AM also confers morphological and cellular changes to the uterine epithelium and stroma that are associated with endometrial receptivity and believed to be beneficial for implantation. We also test mid-regional pro-adrenomedullin (MR-proADM), a stable surrogate for AM peptide, as a biomarker for endometriosis, which is comorbid with infertility. Our studies identify novel mechanisms of action of AM in the endometrium in support of implantation and the establishment of pregnancy, providing a foundational basis for the use of AM as a clinical therapeutic for infertility.
In Part II, we address the role of AM in the maintenance of a healthy pregnancy by expanding upon previous studies in mouse models with clinical samples from women with severe preeclampsia, a placental vascular disorder characterized by hypertension and proteinuria. Because Adm-/- placentas exhibit a preeclampsia-like phenotype, we test the hypothesis that MR-proADM concentrations are decreased in plasma from women with severe preeclampsia. Indeed, we find that MR-proADM levels are blunted in women with severe preeclampsia and that MR-proADM is similarly effective as other established biomarkers of preeclampsia at distinguishing between cases and controls. Altogether, our studies in both mice and humans point to diagnostic and therapeutic applications for AM in the context of female reproductive disease.
2017-12
2017
Physiology
Cellular biology
Endocrinology
adrenomedullin, endometriosis, implantation, in vitro fertilization, preeclampsia, pregnancy
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Cell Biology and Physiology
Kathleen
Caron
Thesis advisor
Keith
Burridge
Thesis advisor
Richard
Cheney
Thesis advisor
Robert
Tarran
Thesis advisor
Steven
Young
Thesis advisor
text
Brooke
Matson
Creator
Department of Cell Biology and Physiology
School of Medicine
Molecular Regulators of Embryo Implantation and Pregnancy
Embryo implantation is one of the first steps in the establishment of pregnancy and sets the stage for proper embryonic and placental development. We are beginning to appreciate the complexity of implantation and its demand for synchrony between embryo and endometrium. Over the years, many groups have identified and studied both embryonic and endometrial factors affecting implantation, but there is still much to learn. Here, we focus on the endocrine peptide adrenomedullin (Adm, AM) and its association with female reproductive physiology and disease in both mice and humans.
In Part I, we elaborate on the subfertility phenotype of Adm heterozygous female mice by testing whether AM supplementation before implantation can improve fertility and pregnancy outcomes. We find that administration of AM directly to the mouse uterus before blastocyst transfer enhances implantation success and inter-embryonic spacing. Intra-uterine delivery of AM also confers morphological and cellular changes to the uterine epithelium and stroma that are associated with endometrial receptivity and believed to be beneficial for implantation. We also test mid-regional pro-adrenomedullin (MR-proADM), a stable surrogate for AM peptide, as a biomarker for endometriosis, which is comorbid with infertility. Our studies identify novel mechanisms of action of AM in the endometrium in support of implantation and the establishment of pregnancy, providing a foundational basis for the use of AM as a clinical therapeutic for infertility.
In Part II, we address the role of AM in the maintenance of a healthy pregnancy by expanding upon previous studies in mouse models with clinical samples from women with severe preeclampsia, a placental vascular disorder characterized by hypertension and proteinuria. Because Adm-/- placentas exhibit a preeclampsia-like phenotype, we test the hypothesis that MR-proADM concentrations are decreased in plasma from women with severe preeclampsia. Indeed, we find that MR-proADM levels are blunted in women with severe preeclampsia and that MR-proADM is similarly effective as other established biomarkers of preeclampsia at distinguishing between cases and controls. Altogether, our studies in both mice and humans point to diagnostic and therapeutic applications for AM in the context of female reproductive disease.
2017-12
2017
Physiology
Cellular biology
Endocrinology
adrenomedullin, endometriosis, implantation, in vitro fertilization, preeclampsia, pregnancy
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Cell Biology and Physiology
Kathleen
Caron
Thesis advisor
Keith
Burridge
Thesis advisor
Richard
Cheney
Thesis advisor
Robert
Tarran
Thesis advisor
Steven
Young
Thesis advisor
text
Brooke
Matson
Creator
Department of Cell Biology and Physiology
School of Medicine
Molecular Regulators of Embryo Implantation and Pregnancy
Embryo implantation is one of the first steps in the establishment of pregnancy and sets the stage for proper embryonic and placental development. We are beginning to appreciate the complexity of implantation and its demand for synchrony between embryo and endometrium. Over the years, many groups have identified and studied both embryonic and endometrial factors affecting implantation, but there is still much to learn. Here, we focus on the endocrine peptide adrenomedullin (Adm, AM) and its association with female reproductive physiology and disease in both mice and humans.
In Part I, we elaborate on the subfertility phenotype of Adm heterozygous female mice by testing whether AM supplementation before implantation can improve fertility and pregnancy outcomes. We find that administration of AM directly to the mouse uterus before blastocyst transfer enhances implantation success and inter-embryonic spacing. Intra-uterine delivery of AM also confers morphological and cellular changes to the uterine epithelium and stroma that are associated with endometrial receptivity and believed to be beneficial for implantation. We also test mid-regional pro-adrenomedullin (MR-proADM), a stable surrogate for AM peptide, as a biomarker for endometriosis, which is comorbid with infertility. Our studies identify novel mechanisms of action of AM in the endometrium in support of implantation and the establishment of pregnancy, providing a foundational basis for the use of AM as a clinical therapeutic for infertility.
In Part II, we address the role of AM in the maintenance of a healthy pregnancy by expanding upon previous studies in mouse models with clinical samples from women with severe preeclampsia, a placental vascular disorder characterized by hypertension and proteinuria. Because Adm-/- placentas exhibit a preeclampsia-like phenotype, we test the hypothesis that MR-proADM concentrations are decreased in plasma from women with severe preeclampsia. Indeed, we find that MR-proADM levels are blunted in women with severe preeclampsia and that MR-proADM is similarly effective as other established biomarkers of preeclampsia at distinguishing between cases and controls. Altogether, our studies in both mice and humans point to diagnostic and therapeutic applications for AM in the context of female reproductive disease.
2017-12
2017
Physiology
Cellular biology
Endocrinology
adrenomedullin, endometriosis, implantation, in vitro fertilization, preeclampsia, pregnancy
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Cell Biology and Physiology
Kathleen
Caron
Thesis advisor
Keith
Burridge
Thesis advisor
Richard
Cheney
Thesis advisor
Robert
Tarran
Thesis advisor
Steven
Young
Thesis advisor
text
Brooke
Matson
Creator
Department of Cell Biology and Physiology
School of Medicine
Molecular Regulators of Embryo Implantation and Pregnancy
Embryo implantation is one of the first steps in the establishment of pregnancy and sets the stage for proper embryonic and placental development. We are beginning to appreciate the complexity of implantation and its demand for synchrony between embryo and endometrium. Over the years, many groups have identified and studied both embryonic and endometrial factors affecting implantation, but there is still much to learn. Here, we focus on the endocrine peptide adrenomedullin (Adm, AM) and its association with female reproductive physiology and disease in both mice and humans.
In Part I, we elaborate on the subfertility phenotype of Adm heterozygous female mice by testing whether AM supplementation before implantation can improve fertility and pregnancy outcomes. We find that administration of AM directly to the mouse uterus before blastocyst transfer enhances implantation success and inter-embryonic spacing. Intra-uterine delivery of AM also confers morphological and cellular changes to the uterine epithelium and stroma that are associated with endometrial receptivity and believed to be beneficial for implantation. We also test mid-regional pro-adrenomedullin (MR-proADM), a stable surrogate for AM peptide, as a biomarker for endometriosis, which is comorbid with infertility. Our studies identify novel mechanisms of action of AM in the endometrium in support of implantation and the establishment of pregnancy, providing a foundational basis for the use of AM as a clinical therapeutic for infertility.
In Part II, we address the role of AM in the maintenance of a healthy pregnancy by expanding upon previous studies in mouse models with clinical samples from women with severe preeclampsia, a placental vascular disorder characterized by hypertension and proteinuria. Because Adm-/- placentas exhibit a preeclampsia-like phenotype, we test the hypothesis that MR-proADM concentrations are decreased in plasma from women with severe preeclampsia. Indeed, we find that MR-proADM levels are blunted in women with severe preeclampsia and that MR-proADM is similarly effective as other established biomarkers of preeclampsia at distinguishing between cases and controls. Altogether, our studies in both mice and humans point to diagnostic and therapeutic applications for AM in the context of female reproductive disease.
2017-12
2017
Physiology
Cellular biology
Endocrinology
adrenomedullin, endometriosis, implantation, in vitro fertilization, preeclampsia, pregnancy
eng
Doctor of Philosophy
Dissertation
Cell Biology and Physiology
Kathleen
Caron
Thesis advisor
Keith
Burridge
Thesis advisor
Richard
Cheney
Thesis advisor
Robert
Tarran
Thesis advisor
Steven
Young
Thesis advisor
text
University of North Carolina at Chapel Hill
Degree granting institution
Brooke
Matson
Creator
Department of Cell Biology and Physiology
School of Medicine
Molecular Regulators of Embryo Implantation and Pregnancy
Embryo implantation is one of the first steps in the establishment of pregnancy and sets the stage for proper embryonic and placental development. We are beginning to appreciate the complexity of implantation and its demand for synchrony between embryo and endometrium. Over the years, many groups have identified and studied both embryonic and endometrial factors affecting implantation, but there is still much to learn. Here, we focus on the endocrine peptide adrenomedullin (Adm, AM) and its association with female reproductive physiology and disease in both mice and humans.
In Part I, we elaborate on the subfertility phenotype of Adm heterozygous female mice by testing whether AM supplementation before implantation can improve fertility and pregnancy outcomes. We find that administration of AM directly to the mouse uterus before blastocyst transfer enhances implantation success and inter-embryonic spacing. Intra-uterine delivery of AM also confers morphological and cellular changes to the uterine epithelium and stroma that are associated with endometrial receptivity and believed to be beneficial for implantation. We also test mid-regional pro-adrenomedullin (MR-proADM), a stable surrogate for AM peptide, as a biomarker for endometriosis, which is comorbid with infertility. Our studies identify novel mechanisms of action of AM in the endometrium in support of implantation and the establishment of pregnancy, providing a foundational basis for the use of AM as a clinical therapeutic for infertility.
In Part II, we address the role of AM in the maintenance of a healthy pregnancy by expanding upon previous studies in mouse models with clinical samples from women with severe preeclampsia, a placental vascular disorder characterized by hypertension and proteinuria. Because Adm-/- placentas exhibit a preeclampsia-like phenotype, we test the hypothesis that MR-proADM concentrations are decreased in plasma from women with severe preeclampsia. Indeed, we find that MR-proADM levels are blunted in women with severe preeclampsia and that MR-proADM is similarly effective as other established biomarkers of preeclampsia at distinguishing between cases and controls. Altogether, our studies in both mice and humans point to diagnostic and therapeutic applications for AM in the context of female reproductive disease.
2017-12
2017
Physiology
Cellular biology
Endocrinology
adrenomedullin, endometriosis, implantation, in vitro fertilization, preeclampsia, pregnancy
eng
Doctor of Philosophy
Dissertation
Cell Biology and Physiology
Kathleen
Caron
Thesis advisor
Keith
Burridge
Thesis advisor
Richard
Cheney
Thesis advisor
Robert
Tarran
Thesis advisor
Steven
Young
Thesis advisor
text
University of North Carolina at Chapel Hill
Degree granting institution
Brooke
Matson
Creator
Department of Cell Biology and Physiology
School of Medicine
Molecular Regulators of Embryo Implantation and Pregnancy
Embryo implantation is one of the first steps in the establishment of pregnancy and sets the stage for proper embryonic and placental development. We are beginning to appreciate the complexity of implantation and its demand for synchrony between embryo and endometrium. Over the years, many groups have identified and studied both embryonic and endometrial factors affecting implantation, but there is still much to learn. Here, we focus on the endocrine peptide adrenomedullin (Adm, AM) and its association with female reproductive physiology and disease in both mice and humans.
In Part I, we elaborate on the subfertility phenotype of Adm heterozygous female mice by testing whether AM supplementation before implantation can improve fertility and pregnancy outcomes. We find that administration of AM directly to the mouse uterus before blastocyst transfer enhances implantation success and inter-embryonic spacing. Intra-uterine delivery of AM also confers morphological and cellular changes to the uterine epithelium and stroma that are associated with endometrial receptivity and believed to be beneficial for implantation. We also test mid-regional pro-adrenomedullin (MR-proADM), a stable surrogate for AM peptide, as a biomarker for endometriosis, which is comorbid with infertility. Our studies identify novel mechanisms of action of AM in the endometrium in support of implantation and the establishment of pregnancy, providing a foundational basis for the use of AM as a clinical therapeutic for infertility.
In Part II, we address the role of AM in the maintenance of a healthy pregnancy by expanding upon previous studies in mouse models with clinical samples from women with severe preeclampsia, a placental vascular disorder characterized by hypertension and proteinuria. Because Adm-/- placentas exhibit a preeclampsia-like phenotype, we test the hypothesis that MR-proADM concentrations are decreased in plasma from women with severe preeclampsia. Indeed, we find that MR-proADM levels are blunted in women with severe preeclampsia and that MR-proADM is similarly effective as other established biomarkers of preeclampsia at distinguishing between cases and controls. Altogether, our studies in both mice and humans point to diagnostic and therapeutic applications for AM in the context of female reproductive disease.
2017-12
2017
Physiology
Cellular biology
Endocrinology
adrenomedullin; endometriosis; implantation; in vitro fertilization; preeclampsia; pregnancy
eng
Doctor of Philosophy
Dissertation
Cell Biology and Physiology
Kathleen
Caron
Thesis advisor
Keith
Burridge
Thesis advisor
Richard
Cheney
Thesis advisor
Robert
Tarran
Thesis advisor
Steven
Young
Thesis advisor
text
University of North Carolina at Chapel Hill
Degree granting institution
Brooke
Matson
Creator
Department of Cell Biology and Physiology
School of Medicine
Molecular Regulators of Embryo Implantation and Pregnancy
Embryo implantation is one of the first steps in the establishment of pregnancy and sets the stage for proper embryonic and placental development. We are beginning to appreciate the complexity of implantation and its demand for synchrony between embryo and endometrium. Over the years, many groups have identified and studied both embryonic and endometrial factors affecting implantation, but there is still much to learn. Here, we focus on the endocrine peptide adrenomedullin (Adm, AM) and its association with female reproductive physiology and disease in both mice and humans.
In Part I, we elaborate on the subfertility phenotype of Adm heterozygous female mice by testing whether AM supplementation before implantation can improve fertility and pregnancy outcomes. We find that administration of AM directly to the mouse uterus before blastocyst transfer enhances implantation success and inter-embryonic spacing. Intra-uterine delivery of AM also confers morphological and cellular changes to the uterine epithelium and stroma that are associated with endometrial receptivity and believed to be beneficial for implantation. We also test mid-regional pro-adrenomedullin (MR-proADM), a stable surrogate for AM peptide, as a biomarker for endometriosis, which is comorbid with infertility. Our studies identify novel mechanisms of action of AM in the endometrium in support of implantation and the establishment of pregnancy, providing a foundational basis for the use of AM as a clinical therapeutic for infertility.
In Part II, we address the role of AM in the maintenance of a healthy pregnancy by expanding upon previous studies in mouse models with clinical samples from women with severe preeclampsia, a placental vascular disorder characterized by hypertension and proteinuria. Because Adm-/- placentas exhibit a preeclampsia-like phenotype, we test the hypothesis that MR-proADM concentrations are decreased in plasma from women with severe preeclampsia. Indeed, we find that MR-proADM levels are blunted in women with severe preeclampsia and that MR-proADM is similarly effective as other established biomarkers of preeclampsia at distinguishing between cases and controls. Altogether, our studies in both mice and humans point to diagnostic and therapeutic applications for AM in the context of female reproductive disease.
2017-12
2017
Physiology
Cellular biology
Endocrinology
adrenomedullin, endometriosis, implantation, in vitro fertilization, preeclampsia, pregnancy
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Cell Biology and Physiology
Kathleen
Caron
Thesis advisor
Keith
Burridge
Thesis advisor
Richard
Cheney
Thesis advisor
Robert
Tarran
Thesis advisor
Steven
Young
Thesis advisor
text
Brooke
Matson
Creator
Department of Cell Biology and Physiology
School of Medicine
Molecular Regulators of Embryo Implantation and Pregnancy
Embryo implantation is one of the first steps in the establishment of pregnancy and sets the stage for proper embryonic and placental development. We are beginning to appreciate the complexity of implantation and its demand for synchrony between embryo and endometrium. Over the years, many groups have identified and studied both embryonic and endometrial factors affecting implantation, but there is still much to learn. Here, we focus on the endocrine peptide adrenomedullin (Adm, AM) and its association with female reproductive physiology and disease in both mice and humans.
In Part I, we elaborate on the subfertility phenotype of Adm heterozygous female mice by testing whether AM supplementation before implantation can improve fertility and pregnancy outcomes. We find that administration of AM directly to the mouse uterus before blastocyst transfer enhances implantation success and inter-embryonic spacing. Intra-uterine delivery of AM also confers morphological and cellular changes to the uterine epithelium and stroma that are associated with endometrial receptivity and believed to be beneficial for implantation. We also test mid-regional pro-adrenomedullin (MR-proADM), a stable surrogate for AM peptide, as a biomarker for endometriosis, which is comorbid with infertility. Our studies identify novel mechanisms of action of AM in the endometrium in support of implantation and the establishment of pregnancy, providing a foundational basis for the use of AM as a clinical therapeutic for infertility.
In Part II, we address the role of AM in the maintenance of a healthy pregnancy by expanding upon previous studies in mouse models with clinical samples from women with severe preeclampsia, a placental vascular disorder characterized by hypertension and proteinuria. Because Adm-/- placentas exhibit a preeclampsia-like phenotype, we test the hypothesis that MR-proADM concentrations are decreased in plasma from women with severe preeclampsia. Indeed, we find that MR-proADM levels are blunted in women with severe preeclampsia and that MR-proADM is similarly effective as other established biomarkers of preeclampsia at distinguishing between cases and controls. Altogether, our studies in both mice and humans point to diagnostic and therapeutic applications for AM in the context of female reproductive disease.
2017-12
2017
Physiology
Cellular biology
Endocrinology
adrenomedullin, endometriosis, implantation, in vitro fertilization, preeclampsia, pregnancy
eng
Doctor of Philosophy
Dissertation
Cell Biology and Physiology
Kathleen
Caron
Thesis advisor
Keith
Burridge
Thesis advisor
Richard
Cheney
Thesis advisor
Robert
Tarran
Thesis advisor
Steven
Young
Thesis advisor
text
University of North Carolina at Chapel Hill
Degree granting institution
Brooke
Matson
Creator
Department of Cell Biology and Physiology
School of Medicine
Molecular Regulators of Embryo Implantation and Pregnancy
Embryo implantation is one of the first steps in the establishment of pregnancy and sets the stage for proper embryonic and placental development. We are beginning to appreciate the complexity of implantation and its demand for synchrony between embryo and endometrium. Over the years, many groups have identified and studied both embryonic and endometrial factors affecting implantation, but there is still much to learn. Here, we focus on the endocrine peptide adrenomedullin (Adm, AM) and its association with female reproductive physiology and disease in both mice and humans.
In Part I, we elaborate on the subfertility phenotype of Adm heterozygous female mice by testing whether AM supplementation before implantation can improve fertility and pregnancy outcomes. We find that administration of AM directly to the mouse uterus before blastocyst transfer enhances implantation success and inter-embryonic spacing. Intra-uterine delivery of AM also confers morphological and cellular changes to the uterine epithelium and stroma that are associated with endometrial receptivity and believed to be beneficial for implantation. We also test mid-regional pro-adrenomedullin (MR-proADM), a stable surrogate for AM peptide, as a biomarker for endometriosis, which is comorbid with infertility. Our studies identify novel mechanisms of action of AM in the endometrium in support of implantation and the establishment of pregnancy, providing a foundational basis for the use of AM as a clinical therapeutic for infertility.
In Part II, we address the role of AM in the maintenance of a healthy pregnancy by expanding upon previous studies in mouse models with clinical samples from women with severe preeclampsia, a placental vascular disorder characterized by hypertension and proteinuria. Because Adm-/- placentas exhibit a preeclampsia-like phenotype, we test the hypothesis that MR-proADM concentrations are decreased in plasma from women with severe preeclampsia. Indeed, we find that MR-proADM levels are blunted in women with severe preeclampsia and that MR-proADM is similarly effective as other established biomarkers of preeclampsia at distinguishing between cases and controls. Altogether, our studies in both mice and humans point to diagnostic and therapeutic applications for AM in the context of female reproductive disease.
2017-12
2017
Physiology
Cellular biology
Endocrinology
adrenomedullin; endometriosis; implantation; in vitro fertilization; preeclampsia; pregnancy
eng
Doctor of Philosophy
Dissertation
Kathleen
Caron
Thesis advisor
Keith
Burridge
Thesis advisor
Richard
Cheney
Thesis advisor
Robert
Tarran
Thesis advisor
Steven
Young
Thesis advisor
text
University of North Carolina at Chapel Hill
Degree granting institution
Matson_unc_0153D_17404.pdf
uuid:7fc70ef1-ceae-4851-94bf-36c57a347fe5
2019-12-31T00:00:00
2017-11-16T15:47:06Z
proquest
application/pdf
2890653